This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
May 11, 2022
Bulletin from the annual general meeting of Vicore Pharma Holding AB (publ)
May 11, 2022
Targovax to present at upcoming conferences
May 10, 2022
Fusion Pharmaceuticals Announces First Quarter 2022 Financial Results And Clinical Program Updates
May 10, 2022
Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma
May 06, 2022
Nordic Nanovector ASA: Invitation to First Quarter 2022 Results Presentation and Webcast
May 05, 2022
Interim report January – March 2022
May 04, 2022
Xeris Biopharma to Report First Quarter 2022 Financial Results on May 11, 2022
May 04, 2022
BONESUPPORT Holding AB (publ) – Publishes Q1 2022 interim report
May 04, 2022
Oncopeptides publishes Q1 report 2022
May 03, 2022
Pulmonx Reports First Quarter 2022 Financial Results